London, United Kingdom
Professor
University of London
Professor of Vascular Surgery
St. Georges Vascular Institute
SCHEDULE FOR VEITHsymposium™
Tuesday, November 18, 2014
Presenter
SESSION 3: TYPE B AORTIC DISSECTIONS (TBADS) AND THEIR TREATMENT
DEBATE: With Patients Having Uncomplicated TBAD Medical Treatment With Delayed (2-3 Months) TEVAR Is The Best Treatment: It Will Lessen Complications Including Retrograde Type A Dissections
9:43 AM - 9:48 AM
Presenter
SESSION 8: MORE ON THORACIC AORTIC DISEASE, TEVAR AND TBADS
Relationship Between Aortic Morphology After TEVAR And Clinical Outcomes With TBADs
5:36 PM - 5:41 PM
Presenter
SESSION 20: OPTIMAL PERIPROCEDURAL MEDICAL MANAGEMENT IN VASCULAR PATIENTS; SOME INTERESTING HISTORY AND TECHNOLOGY; THE CCSVI FOR MULTIPLE SCLEROSIS (MS) CONTROVERSY
Scandalous High Long-Term Mortality After EVAR: It Is Due To MD Ignorance Regarding Statins And Other Medical Treatment: The AAA Is Fixed But MIs Kill: Statins Should Be In The Drinking Water
10:11 AM - 10:16 AM
Wednesday, November 19, 2014
Session Moderator
SESSION-33: NEW DEVELOPMENTS IN THE TREATMENT OF RUPTURED AAAS
Presenter
SESSION 33: NEW DEVELOPMENTS IN THE TREATMENT OF RUPTURED AAAS
Why Are Treatment Outcomes For RAAAs Better In The US Than In The UK: Hints For Improving Results And Support For The Position That EVAR Is Better Than Open Repair
5:52 PM - 5:57 PM
Thursday, November 20, 2014
Session Moderator
SESSION-58: NEW OR IMPROVED ENDOGRAFTS, DEVICES, TECHNOLOGIES AND INFORMATION FOR TREATING THORACIC AORTIC DISEASE AND COMPLEX ANEURYSMS
Friday, November 21, 2014
Presenter
SESSION 75: MORE ABOUT THORACIC AND ABDOMINAL AORTIC DISEASE AND AORTIC DISSECTIONS; LARGE SHEATH ENDOVASCULAR ACCESS
Which Patients Should Not Be Treated By TEVAR For Aneurysms Or TBADs Because Their 3-Year Mortality Or Reintervention Rates Are So High
8:10 AM - 8:15 AM
 
previous next